FTC Issues Second Request To Watson, Andrx
The proposed marriage of generic drug makers Watson Pharmaceuticals Inc. and Andrx Corp. has drawn new attention from the Federal Trade Commission, which issued a second request for information in order...To view the full article, register now.
Already a subscriber? Click here to view full article